InvestorsHub Logo
icon url

Toxic Avenger

02/27/09 8:31 AM

#31067 RE: sneaky_peaky #31052

So much for ignore, I guess. Anyway, I suggest a good line-by-line comparison of their financial statements if you want to understand why HANS is at almost $3 billion in valuation and DKAM is at less than $20 million.
You are right that the potential for growth at a company with $1 billion in sales is less than at one with $2.5-$6 million, but then again, the likelihood of going under is greatly reduced as well.
As for HANS growth being over, that may be true, but so far they've had impressive Y over Y growth up through last reported year ending 12/31/08, whereas DKAM's has been far more erratic (and I'm being generous).